Effect of SwitChing AtriPla to Eviplera on Neurocognitive and Emotional Functioning, ESCAPE Study
Phase of Trial: Phase IV
Latest Information Update: 28 Oct 2016
At a glance
- Drugs Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- Acronyms ESCAPE
- 27 Oct 2016 Planned End Date changed from 1 Apr 2016 to 1 Jan 2017.
- 27 Oct 2016 Status changed from not yet recruiting to recruiting.
- 22 Oct 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Nov 2016.